SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 12.73 |
| Enterprise Value ($M) | 5.52 |
| Book Value ($M) | 57.20 |
| Book Value / Share | 1.49 |
| Price / Book | 0.22 |
| NCAV ($M) | 8.38 |
| NCAV / Share | 0.22 |
| Price / NCAV | 1.52 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.77 |
| Return on Assets (ROA) | -0.44 |
| Return on Equity (ROE) | -0.61 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.20 |
| Current Ratio | 3.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 50.81 |
| Assets | 99.63 |
| Liabilities | 42.43 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 7.69 |
| Operating Income | -68.24 |
| Net Income | -63.12 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -61.29 |
| Cash from Investing | 57.58 |
| Cash from Financing | 0.11 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Citadel Advisors Llc | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 9,526 | 31,936 | 29.83 | |
| 974 | 61,756 | 1.58 | |
| 133,278 | 254,213 | 52.43 | |
| 55,255 | 155,248 | 35.59 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BIVI – BioVie Inc. | BMRA – Biomerica, Inc. |
| BNTC – Benitec Biopharma Inc. | BON – Bon Natural Life Limited |
| BTAI – BioXcel Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io